Avanos Medical Inc (AVNS)
19.39
-0.10
(-0.51%)
USD |
NYSE |
Nov 14, 10:39
Avanos Medical Debt to Equity Ratio: 0.1317 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1317 |
| June 30, 2024 | 0.1433 |
| March 31, 2024 | 0.1438 |
| December 31, 2023 | 0.1359 |
| September 30, 2023 | 0.2164 |
| June 30, 2023 | 0.1697 |
| March 31, 2023 | 0.1624 |
| December 31, 2022 | 0.1801 |
| September 30, 2022 | 0.201 |
| June 30, 2022 | 0.2029 |
| March 31, 2022 | 0.2025 |
| December 31, 2021 | 0.1023 |
| September 30, 2021 | 0.1149 |
| June 30, 2021 | 0.1273 |
| March 31, 2021 | 0.1397 |
| December 31, 2020 | 0.1433 |
| September 30, 2020 | 0.1927 |
| June 30, 2020 | 0.1969 |
| March 31, 2020 | 0.1975 |
| December 31, 2019 | 0.1961 |
| September 30, 2019 | 0.1957 |
| June 30, 2019 | 0.1941 |
| Date | Value |
|---|---|
| March 31, 2019 | 0.1937 |
| December 31, 2018 | 0.1909 |
| September 30, 2018 | 0.1904 |
| June 30, 2018 | 0.1923 |
| March 31, 2018 | 0.433 |
| December 31, 2017 | 0.4779 |
| September 30, 2017 | 0.4916 |
| June 30, 2017 | 0.5013 |
| March 31, 2017 | 0.5123 |
| December 31, 2016 | 0.5252 |
| September 30, 2016 | 0.5351 |
| June 30, 2016 | 0.5727 |
| March 31, 2016 | 0.5357 |
| December 31, 2015 | 0.5478 |
| September 30, 2015 | 0.5628 |
| June 30, 2015 | 0.3849 |
| March 31, 2015 | 0.4202 |
| December 31, 2014 | 0.4201 |
| September 30, 2014 | 0.0052 |
| June 30, 2014 | 0.005 |
| March 31, 2014 | 0.0045 |
| December 31, 2013 | 0.0057 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1023
Minimum
Dec 2021
0.2164
Maximum
Sep 2023
0.165
Average
0.166
Median
Debt to Equity Ratio Benchmarks
| Globus Medical Inc | 0.1074 |
| NeuroOne Medical Technologies Corp | 0.00 |
| SINTX Technologies Inc | 0.0272 |
| Nutriband Inc | 0.0158 |
| enVVeno Medical Corp | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.656B |
| Total Liabilities (Quarterly) | 426.50M |
| Shareholders Equity (Quarterly) | 1.230B |
| Current Ratio | 2.220 |
| Net Debt Paydown Yield | 0.86% |